CME Webcast

Incorporating Novel Approaches for Lipid Management

For AAFP members only

Patient getting blood drawn

Better manage your patients’ lipid profile, and earn free CME

More than 25% of American adults older than 40 have elevated cholesterol, despite advances in pharmacologic treatment of dyslipidemia. Learn the latest evidence-based recommendations and guidelines to help manage your patients’ lipid profile

Enhance your patient care today and earn up to 2 additional AAFP Prescribed credits when you complete the Translation to Practice® process.

About the Webcast

Learning Objectives

After completing this CME activity, you should be able to:

  • Describe the biochemical basis of abnormal lipid metabolism, noting areas that are targeted in both current and potential future therapies.
  • Describe an evidence-based therapeutic approach to the patient with a true intolerance to statin therapy.
  • Outline a treatment plan for the patient who has an inadequate response to high intensity statin therapy, including strategies to rule out suboptimal adherence and optimization of patient education.
  • Describe the integration of shared decision-making into the clinical encounter for a patient with elevated LDL-cholesterol.

Estimated time required to complete the full module: 1 hour and 23 minutes

Original release date of webcast: February 15, 2016.

Flash Player is required to view this webcast. Some mobile devices may not be compatible. View the system requirements.

Have you completed this activity?

Take the post-test »

Presenting Faculty

Lynne T. Braun PhD, CNP, FAHA, FPCNA, FAAN, Rush University and Heart & Vascular Institute, Chicago, IL

Kathy Berra MSN, ANP-BC, FAHA, FPCNA, FAAN, Stanford Prevention Research Center, Stanford, CA

Jonathon M. Firnhaber, MD, FAAFP, East Carolina University, Brody School of Medicine, Greenville, NC

Funding

This program was funded in part by professional education grant from Pfizer, Inc.

The American Academy of Family Physicians developed this CME activity in collaboration with the Preventive Cardiovascular Nurses Association.

CME Credit

To be eligible to report CME credit, please complete the full module in one sitting.

This enduring material activity, Incorporating Novel Approaches for Lipid Management, has been reviewed and is acceptable for up to 1.5 Prescribed credits by the American Academy of Family Physicians. Term of approval begins February 9, 2016. Term of approval is for two years from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Academy of Family Physicians designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit. View more credit agreements »

Disclaimer

The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note that medical information is constantly changing; the information contained in this activity was accurate at the time of publication. This material is not intended to represent the only, nor necessarily best, methods or procedures appropriate for the medical situations discussed. Rather, it is intended to present an approach, view, statement, or opinion of the faculty, which may be helpful to others who face similar situations.

The AAFP disclaims any and all liability for injury or other damages resulting to any individual using this material and for all claims that might arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by a physician or any other person. Physicians may care to check specific details such as drug doses and contraindications, etc., in standard sources prior to clinical application. This material might contain recommendations/guidelines developed by other organizations. Please note that although these guidelines might be included, this does not necessarily imply the endorsement by the AAFP.

Have you completed this activity?

Take the post-test »